Does Insurance Cover Zepbound for Sleep Apnea?

Yes, insurance often covers Zepbound for sleep apnea, but approval is conditional. After the FDA cleared tirzepatide in December 2024 as the first medication for moderate to severe obstructive sleep apnea in adults with obesity, most commercial plans added it to their formularies for that use.1U.S. Food and Drug Administration. FDA Approves First Medication for Obstructive Sleep Apnea Nearly all of them require prior authorization, proof that CPAP or another PAP device failed or isn’t an option, and documented clinical thresholds for both your sleep apnea severity and your weight. Getting to yes is a paperwork problem more than a policy one, and knowing what your plan needs before your doctor submits the request is the difference between a two-week approval and a months-long appeal.

Why the FDA Approval Matters for Your Claim

Zepbound’s sleep apnea approval is separate from its earlier clearance for chronic weight management.2U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management That distinction shapes how insurers treat the prescription. A doctor writing Zepbound for OSA is using it for an FDA-approved indication, not off-label, which strips insurers of one of their easiest denial rationales.

It also matters for plans that exclude anti-obesity drugs. Many employer plans have blanket exclusions for weight-loss medications, and some insurers still try to apply that exclusion to Zepbound. The sleep apnea indication gives you a direct counter-argument: the prescription treats OSA, and the drug carries a specific FDA approval for that condition.

What Your Plan Will Require

Prior authorization criteria vary by insurer, but commercial plans have converged on a similar set of requirements. UnitedHealthcare’s policy is representative:

If your AHI falls between 5 and 15, your plan likely won’t approve Zepbound for sleep apnea regardless of how much your symptoms bother you. Mild OSA falls outside the FDA indication, and insurers hold that line.

Approvals are almost always time-limited. Initial authorizations typically run six months to a year, and to renew you’ll need proof the drug is working. UnitedHealthcare requires a measurable AHI decrease from baseline for reauthorization before 52 weeks of therapy, and a 50% AHI reduction after 52 weeks.3UnitedHealthcare Commercial Plan. Zepbound (Tirzepatide) Obstructive Sleep Apnea Only – Prior Authorization/Non-Formulary Some plans also require at least 5% body weight loss to keep coverage going.4Caremark. FEP Criteria Zepbound Plan on a follow-up sleep study before your renewal comes due.

How to Make the Prior Authorization Succeed

The strongest submissions include the full sleep study report with the AHI score, a recent BMI measurement, a detailed PAP therapy history (or a clinical explanation of why PAP isn’t viable for you), and a letter from your prescriber tying it all together. Missing or vague documentation is the most common cause of delay. Ask your doctor’s office what they plan to submit before it goes in, and offer to help track down anything that’s missing from your records.

Medicare Coverage Works Differently

Federal law excludes drugs used “for weight loss” from the standard Part D benefit.5Office of the Assistant Secretary for Planning and Evaluation. Medicare Coverage of Anti-Obesity Medications Zepbound prescribed for obstructive sleep apnea is not being used for weight loss under that definition, so it falls within the basic Part D benefit and can be covered through your Part D plan’s normal formulary process.6Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge

That’s the theory. In practice, Part D plans set their own formularies, and many have been slow to add Zepbound for OSA. You’ll still need to go through prior authorization, and if the drug isn’t on your plan’s formulary you’ll need to request a formulary exception. Make sure the prescription is coded for the sleep apnea indication rather than weight management, or it may route into the wrong coverage pathway and get rejected reflexively.

If Your Claim Is Denied

GLP-1 medications have high denial rates, and a first-round denial is common even when the clinical picture is strong. Read the denial letter carefully; it must state the specific reason, and that reason tells you what to fix.

The typical rejections fall into a few buckets. Some plans invoke a weight-loss drug exclusion despite the OSA approval, which is exactly the kind of denial the FDA indication gives you grounds to challenge. Others cite insufficient PAP therapy documentation, an AHI below their threshold, non-formulary status requiring an exception request rather than a standard prior authorization, or plain incomplete paperwork.

Internal Appeal

You have 180 days from the denial notice to file an internal appeal. Your insurer must decide within 30 days if you haven’t started the medication, or 60 days if it involves care you’ve already received.7HealthCare.gov. Internal Appeals The single most important document in your appeal package is a letter from your prescriber directly addressing the reason for the denial. If the insurer applied a weight-loss exclusion, the letter should emphasize the separate FDA approval for OSA and clarify that the prescription targets sleep apnea, not weight management. Attach anything the original submission was missing.

External Review

If the internal appeal fails, you have four months from the final denial to request an independent external review.8HealthCare.gov. External Review Standard external reviews must be decided within 45 days, and expedited reviews for urgent medical situations must be completed within 72 hours.9Centers for Medicare & Medicaid Services. HHS-Administered Federal External Review Process for Health Insurance Coverage The insurer must accept the external reviewer’s decision.

You can also file a complaint with your state department of insurance if you believe the denial or appeal was handled unfairly.10National Association of Insurance Commissioners. How to File a Complaint and Research Complaints Against Insurance Carriers It doesn’t replace the appeals process, but it puts a regulator on notice.

What You’ll Pay Out of Pocket

Zepbound’s list price is roughly $1,086 for a 28-day supply of prefilled pens. Even with coverage, high-tier and specialty medications commonly carry 25% to 50% coinsurance, which adds up quickly on a drug at that price point. Check your plan’s Summary of Benefits and formulary tier for Zepbound before your first fill so the copay isn’t a surprise.

Eli Lilly offers a savings card for commercially insured patients that can bring the monthly cost down to as little as $25, with maximum annual savings of $1,300. The card requires commercial insurance (even partial coverage counts) and currently expires at the end of 2026. Medicare, Medicaid, and Tricare beneficiaries are not eligible.11Zepbound (tirzepatide). Coverage, Affordability, and Savings

If you’re paying entirely out of pocket, Lilly’s LillyDirect program sells single-patient-use vials at self-pay prices ranging from $299 to $449 per month depending on the dose.11Zepbound (tirzepatide). Coverage, Affordability, and Savings You must agree not to seek insurance reimbursement while using the self-pay program.

Medicare enrollees hit a specific wall: federal law prohibits using manufacturer coupons alongside Part D coverage. You can technically use a coupon in place of Medicare for a given fill, but you’d need to compare the coupon price against your Part D cost to see which is cheaper.12U.S. Department of Health and Human Services Office of Inspector General. Manufacturer Safeguards May Not Prevent Copayment Coupon Use for Part D Drugs Ask your pharmacist to run both prices.

Health savings accounts and flexible spending accounts let you pay for Zepbound with pre-tax dollars whether or not insurance covers it.13Internal Revenue Service. Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans For 2026, HSA contribution limits are $4,400 for individual coverage and $8,750 for family coverage.14Internal Revenue Service. IRS Notice 26-05 At a 22% marginal tax rate, paying through an HSA effectively knocks 22% off the sticker price. FSAs work similarly but carry a use-it-or-lose-it rule, so match your contribution to how many months of medication you realistically expect to fill.